Clinical Trials Logo
  1. Home
  2. Coronary Artery Disease
  3. NCT00817349
  4. Details
NCT00817349 Clinical Trial

Angio-Seal Evolution Device Registry

Coronary Artery Disease Clinical Trial

Official title:
Clinical Registry of the St. Jude Medical Angio-Seal(TM) Evolution(TM) Vascular Closure Device Following Diagnostic and/or Interventional Endovascular Procedures

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00817349
Other study ID # 0801
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2008
Est. completion date April 2010

Study information
Verified date February 2019
Source Abbott Medical Devices
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Collect data on the use of the Angio-Seal Evolution Device in diagnostic and interventional patient populations.

Description:

This multi-center clinical registry is designed to collect data on the use of the Angio-Seal Evolution Device in patients who have had diagnostic and/or interventional procedures through femoral artery access. Data will be collected on a patient's initial screening through hospital discharge and 30 days post-procedure to evaluate major and minor vascular complications as defined in the protocol.

Recruitment information / eligibility
Status Completed
Enrollment 1004
Est. completion date April 2010
Est. primary completion date April 2010
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient is having a diagnostic and/or interventional procedure via femoral artery access.

Exclusion Criteria:

- Patients who are unable to provide written informed consent.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Main Line Health Heart Center: Bryn Mawr Hospital Bryn Mawr Pennsylvania
United States Cooper Health System Camden New Jersey
United States Ohiohealth Research Institute @ Riverside Methodist Hospital Columbus Ohio
United States Altru Health System Hospital Grand Forks North Dakota
United States Baptist Hospital West Knoxville Tennessee
United States Good Samaritan Hospital Los Angeles California
United States Providence Health & Services Portland Oregon
United States Wake Forest University Baptist Medical Center Winston-Salem North Carolina
United States Main Line Health Heart Center: Lankenau Hospitals Wynnewood Pennsylvania
United States Michigan Heart, P.C. Ypsilanti Michigan

Sponsors (1)
Lead Sponsor Collaborator
Abbott Medical Devices

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Collect major vascular complications 30 days post-procedure
Secondary Assess time artery stops bleeding Immediately following procedure
Secondary Collect minor vascular complications 30 days post-procedure
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A